Across FY26–28, Jefferies forecasts double-digit revenue growth for the sector, led by Biocon (14%), boosted by upcoming ...

Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research ...

Trading under DCOY to commence on January 8, 2026Company’s proprietary peptide-conjugate platform leverages AI-enabled computational ...

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced a Master ...

This course offers a strategic edge by refining cloud system classification through CSA principles, preventing compliance pitfalls and inefficiencies. It empowers teams to enhance validation precision ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...

They have also shared an outlook on pharma, telecom, internet platforms, banking, metals and consumer sectors, alongside ...

Monte Rosa Therapeutics (GLUE) commenced an underwritten public offering of $200M of common stock and pre-funded warrants. All shares and warrants in the offering are being sold by the company.

D-Wave Quantum Inc. Q3 revenue nearly doubled as quantum adoption grows. Click for QBTS ROI use cases, revenue mix, and what ...

Frost & Sullivan has released a white paper titled, “How Leading Global Pharma Embraces AI to Automate Regulatory and Medical ...